In vitro assays demonstrated that depletion of AnxA2 significantly inhibited the proliferation, metastasis, and invasion of bladder cancer cells by downregulating the expression of proangiogenic proteins and cytokines. The gene discussed is ANXA2; the disease is urinary bladder cancer.